LOS ANGELES: Alzheimer’s researchers hope the two new wonder drugs will piece together the puzzle of the disease.
Experts say they are optimistic the latest data will show a major advance in attempts to curb devastating brain changes that are associated with the disease.
The highly anticipated findings are set to be published in what researchers hope will be a watershed moment.
On Wednesday the results of two trials will reveal how the drugs target the root causes of the disease, rather than just masking its symptoms.
The world’s leading dementia experts have gathered at the Alzheimer’s Association International Conference in Washington to hear how solanezumab and aducanumab could lead to a cure…